Preventing the Interaction between Coronaviruses Spike Protein and Angiotensin I Converting Enzyme 2: An In Silico Mechanistic Case Study on Emodin as a Potential Model Compound

@article{Dellafiora2020PreventingTI,
  title={Preventing the Interaction between Coronaviruses Spike Protein and Angiotensin I Converting Enzyme 2: An In Silico Mechanistic Case Study on Emodin as a Potential Model Compound},
  author={Luca Dellafiora and Jean-Lou C. M. Dorne and Gianni Galaverna and Chiara Dall’Asta},
  journal={Applied Sciences},
  year={2020},
  volume={10},
  pages={6358}
}
Emodin, a widespread natural anthraquinone, has many biological activities including health-protective and adverse effects Amongst beneficial effects, potential antiviral activity against coronavirus responsible for the severe acute respiratory syndrome outbreak in 2002–2003 has been described associated with the inhibition of the host cells target receptors recognition by the viral Spike protein However, the inhibition mechanisms have not been fully characterized, hindering the rational use of… 

Figures from this paper

SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies

The data indicate that S protein subunits and their variable conformational states significantly affect the virus pathogenesis, infectivity, and evolutionary mutation, leading to a significant reduction of the global health burden of this pandemic.

Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention

Antiviral activities of polyphenols and their impact on immune system modulation could serve as a solid basis for developing polyphenol-based natural approaches for preventing and treating COVID-19.

Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2

Tannic acid is a potent blocker of the interaction between the S-protein and ACE2, which might have the potential to be developed into an effective anti-coronavirus drug, and TS-984 strongly inhibits the interaction of the coronavirus S protein and the human cell ACE2 receptor.

References

SHOWING 1-10 OF 46 REFERENCES

Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2

Structural comparisons suggested that the SARS-CoV S glycoprotein retains a prefusion architecture after trypsin cleavage into the S1 and S2 subunits and acidic pH treatment, however, binding to the receptor opens up the receptor-binding domain of S1, which could promote the release of the S 1-ACE2 complex and S1 monomers from the prefusion spike and trigger the pre- to postfusion conformational transition.

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

High-resolution crystal structures of the receptor-binding domain of the spike protein of SARS-CoV-2 and SARS -CoV in complex with ACE2 provide insights into the binding mode of these coronaviruses and highlight essential ACE2-interacting residues.

Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases

This review will systematically describe potential broad-spectrum coronavirus fusion inhibitors, including antibodies, protease inhibitors, and peptide fusion inhibitor, along with a discussion of their advantages and disadvantages.

Identification of natural compounds with antiviral activities against SARS-associated coronavirus

Antiviral drug discovery against SARS-CoV.

This review aims to provide a comprehensive account of drug discovery on SARS, and discusses currently available strategies for antiviral drug discovery and how these technologies have been utilized to identify potential antiviral agents for the inhibition of SARS-CoV replication.

Structural Similarity with Cholesterol Reveals Crucial Insights into Mechanisms Sustaining the Immunomodulatory Activity of the Mycotoxin Alternariol

The structural similarity with cholesterol is identified as one of the key determinants of the immunomodulatory potential of AOH, which is related to an alteration of a downstream pro-inflammatory signaling cascade.

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

This study presents an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the HCoV–host interactome and drug targets in the human protein–protein interaction network.

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.

This study presents an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the HCoV-host interactome and drug targets in the human protein-protein interaction network.